Real-time PCR is becoming the method of choice for precise quanti®cation of minute amounts of nucleic acids. For proper comparison of samples, almost all quanti®cation methods assume similar PCR ef®-ciencies in the exponential phase of the reaction. However, inhibition of PCR is common when working with biological samples and may invalidate the assumed similarity of PCR ef®ciencies. Here we present a statistical method, Kinetic Outlier Detection (KOD), to detect samples with dissimilar ef®cien-cies. KOD is based on a comparison of PCR ef®-ciency, estimated from the ampli®cation curve of a test sample, with the mean PCR ef®ciency of samples in a training set. KOD is demonstrated and validated on samples with the same initial number of template molecules, where PCR is inhibited to various degrees by elevated concentrations of dNTP; and in detection of cDNA samples with an aberrant ratio of two genes. Translating the dissimilarity in ef®ciency to quantity, KOD identi®es outliers that differ by 1.3±1.9-fold in their quantity from normal samples with a P-value of 0.05. This precision is higher than the minimal 2-fold difference in number of DNA molecules that real-time PCR usually aims to detect. Thus, KOD may be a useful tool for outlier detection in real-time PCR.
INTRODUCTION
The high sensitivity and accuracy of real-time PCR make it the preferred method for quanti®cation of minute amounts of speci®c DNA sequences. It is mainly used in research but is rapidly ®nding its way to high-throughput clinical diagnostics. Quanti®cation by real-time PCR is very sensitive to subtle differences in PCR ef®ciency between samples. Even a small difference of 5% in PCR ef®ciency will result in a 3-fold difference in the amount of DNA after 25 cycles of exponential ampli®cation. Hence, for proper quanti®cation, most quanti®cation methods assume that the compared samples have similar PCR ef®ciency (1±3). However, PCR inhibition that substantially impairs the accuracy of the quanti®cation is common and is therefore a major problem when working with biological samples (4±7). Four solutions that take sample-speci®c PCR ef®ciency into account have been suggested (8±11). The ®rst requires running two additional PCR systems in multiplex con®guration, which rather complicates the set up of the system (10) . The second involves extensive dilutions which are not feasible with low copy number sample and are laborious in high throughput studies (9) . The third and fourth solutions quantify the DNA amount by estimating the PCR ef®ciency of each sample (8, 11) and technically are the easiest to implement. However, both studies neglect the variance of the results due to the variance of the measured PCR ef®ciency and consequently leave the usability of these methods an open question. Surprisingly, despite the wide awareness to the problem of dissimilar PCR ef®ciencies and the extensive efforts that have been put forward to solve it, no method to identify dissimilarities in PCR ef®ciency has been published. Therefore, the aim of this study was to develop a tool to detect samples that do not obey the assumption of similar PCR ef®ciencies.
In real-time PCR, the rise in¯uorescence with increasing cycle number re¯ects the ef®ciency of the reaction. PCR ef®ciency can be estimated by ®tting the logarithmic phase of the ampli®cation curve above a certain threshold to an exponential equation (12) or by modeling the entire ampli®c-ation curve (13±15). These approaches are called`kinetic PCR'. The way real-time PCR raw data are processed and analyzed affects the accuracy of the estimation of PCR ef®ciency. Changes in the estimation of PCR ef®ciency may arise from different background subtraction, threshold setting, number of data points ®tted and the ®tting algorithm used. However, when examining whether samples have similar PCR ef®ciency or not, the reproducibility of the estimation is more important than its accuracy. Hence, as long as the same procedure is used to estimate PCR ef®ciencies in all samples, any signi®cant difference between estimated ef®ciencies should re¯ect differences in true ef®ciencies.
In this work, we use kinetic PCR (12) to estimate the PCR ef®ciencies of a large number of samples, then we characterize the variance of the ef®ciency, and ®nally we apply its square root (the standard deviation, S.D.) as the criterion to tell whether a test sample has a PCR ef®ciency similar to that of a training set or not. We name this method Kinetic Outlier Detection (KOD). We test KOD on two systems. In the ®rst system we compare the PCR ef®ciency of a training set based on dilution series of puri®ed PCR product to that of a series of test samples inhibited to various levels by elevated concentrations of dNTP. In the second system we compare the PCR ef®ciency of a training set to that of cDNA samples and identify samples with aberrant gene expression.
MATERIALS AND METHODS

Animal experiments
Fifteen Male Sprague±Dawley rats (B&K Universal AB, Sollentuna, Sweden) weighing 230±260 g at death were used in this study. They were kept at standard laboratory conditions; 0.2 or 0.7 mg/kg of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, dizocilpine (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine, here referred to as (+)-MK 801 hydrogen maleate (Sigma) or saline were administered intraperitoneally 60 min before death. Injection volumes were 5 ml/kg and control animals were given corresponding vehicle injections.
Brie¯y, the rats were sacri®ced by decapitation, their brains quickly removed, put on an ice-chilled Petri dish and dissected into limbic forebrain, corpus striatum, mesencephalon and thalamus. All dissected parts were immediately frozen on dry ice and thereafter stored at ±80°C until used.
RNA isolation and reverse transcription
Total RNA was extracted from the mesencephalon, thalamus, corpus striatum and limbic forebrain of the 15 rats as described (16) , altogether giving 60 RNA samples. RNA pellets were dissolved in MQ water and the sample concentration was determined spectrophotometrically. Reverse transcription was performed in a total volume of 20 ml using a ThermoScript kit (Invitrogen Life Technologies), 1 mg total RNA, 15 U ThermoScript RT, 50 pmol of oligo(dT) 20 , 100 ng random hexamers, 1Q synthesis buffer, 0.05 M DTT, 40 U RNaseOUT and 1 mM dNTP mix (all supplied in the ThermoScript kit). The cDNA synthesis was performed according to the instructions of the manufacturer. PCR amplicons were puri®ed with QIAquick PCR Puri®cation Kit (QIAGEN, Washington, USA) for later use in the dNTP titration experiment.
Real-time PCR measurements
The primers for rat 18S and cyclophilin (accession numbers V01270 and M19533) were designed using Primer3 (http:// www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi). Primers for the 18S assay: 5¢-ACGGAAGGGCACCACCAG-GA-3¢ and 5¢-CACCACCACCCACGGAATCG-3¢, cyclophilin assay: 5¢-GTCTCTTTTCGCCGCTTGCT-3¢ and 5¢-TCTGCTGTCTTTGGAACTTTGTCTG-3¢ were synthesized and puri®ed by MWG Biotech (Ebersberg, Germany). Realtime PCR conditions for the 18S and cyclophilin assay: 1 U Taq DNA polymerase (Sigma±Aldrich, St Louis, MO, USA), 10 mM Tris±HCl at pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 , 0.4 mM of each primer, 0.2 g/l BSA (MBI Fermentas), 0.2 mM dNTP (Sigma±Aldrich, St Louis, MO, USA), 0.2Q SYBR Green I (Molecular Probes, Rockland, ME, USA). The ®nal volume of samples was 20 ml. PCR was inhibited by elevated concentrations of 0.3±1 mM dNTP (17) .
Real-time PCR was measured on a LightCycler (Roche Diagnostics) using the following settings for rat 18S and cyclophilin assays: 15 s pre-incubation at 95°C followed by 50 cycles of denaturation at 95°C for 1 s, annealing at 56°C for 3 s, elongation at 72°C for 7 s. Fluorescence was measured at the end of the elongation phase using 470 nm excitation and 530 nm emission (channel 1). Correct PCR products were con®rmed by agarose gel electrophoresis (2% w/v) and melting curve analysis (18) . The ratio of gene expression was calculated by standard curve (2) , where for every run, a new standard curve was constructed based on the same puri®ed PCR product of the quanti®ed gene.
All computation was done with MATLAB version 6.1.0.450, MathWorks, Inc.
Estimation of PCR ef®ciency
Outlier detection by KOD involves estimating the sample speci®c PCR ef®ciency from the ampli®cation curve. Several methods for estimation of PCR ef®ciency are known (12±14). Here we use Exponential Fit (EF) (12) . In EF, the background signal is removed by subtracting the arithmetic average of the ®ve lowest¯uorescence readings from all data points in the ampli®cation curve. The PCR ef®ciency is then estimated by ®tting selected points ( Fig. 1 ) above a certain threshold to:
where R n is the signal corresponding to the number of template molecules at cycle n and R 0 is the signal corresponding to the initial number of template molecules. E is the PCR ef®ciency (0`E`1, i.e. E = 1 is equal to 100% ef®ciency).
Mathematical model of KOD
Having a method to estimate PCR ef®ciency, the next step was to set a criterion to identify deviating test samples. This was done by comparing PCR ef®ciency of a test sample with the ef®ciencies of a training set composed of 8±15 samples (e.g. dilution series) that were estimated at the same setting of threshold and number of ®tted points. A test sample is classi®ed as an outlier if
Here, F is the cumulative distribution function for the standard normal distribution, e i is the observed ef®ciency of 
RESULTS
Setting optimization
The reliability of KOD is based on precise estimation of PCR ef®ciency. To achieve the highest precision in the estimation, the ®tted points should be in the exponential phase, where PCR ef®ciency is most similar among different ampli®cation curves and constant within each ampli®cation curve (19) .
To verify this assumption we tested ®tting 3±5 data points within and around the exponential region (the liner part of the curve in Fig. 1 
Precision of KOD
The use of KOD is to identify samples with aberrant PCR ef®ciencies that might lead to erroneous quanti®cation. The effect of PCR ef®ciency on cycle of threshold (CT) is given by equation 3 (22):
Here R 0 is the signal corresponding to the initial number of template molecules and R CT is the signal corresponding to the number of template molecules after CT cycles. The CT of a sample inhibited by 1.96 S.D., CT in , which is the criterion for outlier detection is:
The difference in CT values of two samples with identical starting number of template molecules with ef®ciency difference of 1.96 S.D. is:
The ratio of the initial number of template molecules of two samples with a given DCT is (1 + E) DCT , e.g. for DCT = 1 and E = 1 (100% ef®ciency) the sample with the lower CT has twice the amount of initial template molecules than the sample with the higher CT. For a sample with an ef®ciency equal to the mean ef®ciency of the training set and a sample with outlier ef®ciency, i.e. 1 + E ± 1.96QS.D., (1 + E) DCT is the smallest difference in template quantity that can be detected by KOD and hence, is the precision of KOD. Assuming S.D. = 0.02 which was found in the ®rst part of the study, the precision of KOD can be calculated for a given ef®ciency as a function of CT or for the initial number of template molecules. As seen in Figure 3 , the precision is improved as the number of template molecules or PCR ef®ciency increases, but decreasing with increasing S.D.
Improper background subtraction
In 5% of the ampli®cation curves analyzed (650 in total), the lower part had a concave shape after background subtraction when plotted in semi-logarithmic scale, instead of the expected linear shape (Fig. 4) . This could be the result of Under Background Subtraction (UBS), i.e. too low a value has been subtracted from the data, or the existence of varying background¯uorescence that requires a more advanced background subtraction method (21) . Comparing UBS samples to duplicates where background was properly subtracted, the CT values of the UBS samples were shifted about 0.7 cycles to lower values, resulting in about 60% overestimation 
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of the copy number. The opposite phenomenonÐover background subtraction, was observed in about 2% of the samples. Over background subtraction led to underestimation of copy number. Ampli®cation curves with background subtraction aberrations were identi®ed both visually and by KOD.
Testing KOD on samples with equal initial number of template molecules
To ®nd out how well outlier samples can be identi®ed by KOD, we designed a test system based on a training set of 15 uninhibited samples and 11 dNTP inhibited test samples; all were based on a puri®ed PCR product of the18S gene of rat.
The training set was a dilution series and the test samples contained the same amount of template as three of the training set samples. Figure 5 shows the ampli®cation curves of the 11 test samples and the three uninhibited samples. Also indicated is the 95% con®dence interval of the ef®ciency for outlier detection. As seen, the more inhibited the test sample, the higher is its CT value. And as assumed, the ampli®cation curves of the inhibited samples also have lower slopes. This correlation is clearly seen in Figure 6 , where the PCR ef®ciencies of the ampli®cation curves are plotted versus their CT values. A 95% con®dence interval of the ef®ciency is indicated by a horizontal line. Several samples with low PCR ef®ciency are outside the con®dence interval and, hence, are outliers. The CTs of the outliers deviate from the average CT of the uninhibited samples by up to 3.9 cycles. This is equivalent to more than a 10-fold error in the quanti®cation. We repeated this experiment with some different dNTP concentration ranges with a total of 71 test samples. Outlier detection was performed at every setting within the optimal range and the mean number of outliers identi®ed in different settings was 40.2 T 4.5.
Using KOD to improve gene expression analysis
The idea with KOD is to identify erroneously quanti®ed samples. In the following experiment, KOD was used to improve the measurements of relative expression of the 18S and cyclophilin genes in rat. The expression of the two genes was quanti®ed in four brain regions of 15 rats (®ve rats for each drug concentration) giving a total of 60 cDNA samples divided into 12 groups with ®ve samples in each (see Table 1 in the Supplementary Material). Twenty-one outliers were identi®ed by KOD in eight of the 12 groups; no sample had background subtraction problems. Fourteen of the outliers were in groups 7, 8 and 12 leaving a single sample in each of these groups which was not an outlier. Hence, no comparative analysis between outliers and non-outliers in these groups was possible. To test if the outliers give rise to an aberrant 18S/ cyclophilin ratio, the gene expression ratios in each group were ranked by their distance from the median ratio of the group (from 0 for the sample with the median ratio up to 4 for the sample with the most deviating ratio). Assuming the ranks are independent identically distributed uniform random variables, the probability of obtaining by chance a sum of n ranks larger than RANK is:
where E(rank) and V(rank) are the expected value and variance of the rank according to uniform distribution and F is the cumulative distribution function of the standard normal distribution. Seven outliers were included in the calculation. The expected sum of ranks was 14 and the observed sum of ranks was 22. The probability of obtaining by chance a larger or equal sum of rank is 0.01. This means that the 18S/ cyclophilin ratios of the outliers detected by KOD are signi®cantly different from the median ratios.
Having about 15% of the samples outliers, we examined if the relative quanti®cation method of Liu and Saint (8) , which is based on estimation of sample speci®c PCR ef®ciency by EF, improves the accuracy of the quanti®cation. In this method, the expression ratio of target (R 0,T ) to reference (R 0,R ) genes is given by:
where E R and E T , are the sample speci®c ef®ciencies and CT,R and CT,T are the CTs of the reference and target gene, respectively. The assumption was that more accurate quanti®cation will yield a smaller spread of the results. There was no signi®cant difference between the ratios or coef®cients of variance (CV) of the ratios in each group, obtained by Liu and Saint's method and the standard curve method. Replacing the results obtained from the standard curve for outliers by the results of Liu and Saint's method did not reduce the CV of the ratios.
To test whether exclusion of outlier samples reduces the spread of the results, we used Wilcoxon signed rank test to compare the CV of the 18S/cyclophilin ratios in each group when including or excluding outlier samples. In four of the ®ve groups, the CV was lower when outliers were excluded ( Table 1 ). The only group where the CV was not improved (group 5), had the smallest difference in CV when excluding the outliers from the calculation. The probability of such a reduction in CV to occur by chance was 0.06.
DISCUSSION
Real-time PCR is rapidly becoming the method of choice for detection and quanti®cation of nucleic acids. Its broad use has led to the development of various quality assurance and standardization methods for PCR (for review see 23). Some of these methods consider normalization tools (24, 25) or housekeeping genes (26±28), while others examine the reliability and reproducibility of the RT and PCR (29, 30) . DNA polymerase inhibition is established as a major problem in PCR (4, 7, 12, 31) that severely affects the accuracy of the quanti®cation (1, 22) . The most commonly used quanti®cation methods neglect this problem (1,2) and no statistical tool has been available to identify outliers for them. The usability of methods that do take this problem into account (8,9,11) has not been established yet, mainly due to the lack of thorough analysis of variance of PCR ef®ciency and its effect on the precision of the quanti®cation by these methods.
In this work, we have presented a method to identify samples that are erroneously quanti®ed due to aberrant PCR ef®ciency. The PCR ef®ciency of a test sample is estimated by kinetic PCR and compared to the PCR ef®ciency of a training set. A sample with signi®cantly different PCR ef®ciency is considered an outlier.
For KOD to be as sensitive as possible, the PCR ef®ciency should be estimated in the exponential phase of the reaction, where the estimation by EF is most precise and the ef®ciencies of different samples are most similar (19) . The use of different settings in the exponential phase may yield slightly different results. Those`partially detected' samples may require re-run to clear the uncertainty. Two free software packages are available to automatically identify the exponential phase of the ampli®cation curve (11, 21) . We preferred LinRegPCR (11) which also estimates the PCR ef®ciency.
Analyzing a large number of ampli®cation curves, we found background subtraction to be important in the processing of real-time PCR data. If background is inappropriately treated, UBS may introduce substantial errors in quanti®cation by EF. In the software developed for many instruments, background is automatically subtracted and UBS may go unnoticed. The deformed curves caused by UBS were identi®ed either visually or by KOD. Samples with background subtraction problems should be excluded from analysis.
Ideally, outliers should be detected by a single sample two-tailed t-test that is solely based on the training set data. In practice, an external measure of the S.D. of PCR ef®ciency (8) . This value may vary with the detection chemistry, machine or type of training set used. The smaller the S.D. of PCR ef®ciency, the smaller the differences in PCR ef®ciency that can be detected by KOD (Fig. 3) . The use of a training set to control ampli®cation quality is only as good as the samples used in the training set. In essence, the KOD procedure is a test for differences in ampli®cation ef®ciency between a test sample and the training set. If the training set samples are puri®ed preparations, they might not represent the possibly impure experimental cDNA test samples they are to be tested against, and the KOD will detect that experimental and puri®ed samples display different kinetics. The choice of training set is therefore critical to the application of KOD. The main use of the training sets in this study was to characterize the variance of PCR ef®ciency originating from technical factors; hence, to minimize biological in¯uence, the training sets contained standard samples based on puri®ed PCR product. Once S.D. was characterized and the user is only interested in the mean ef®ciency, several alternative training sets can be used. For example, one may construct the standard curve from a dilution series of RNA or cDNA (32, 33) . By serially diluting a cDNA sample to construct the standard curve, the user keeps the training set representative of the experimental test samples even in case that the entire set of test samples contains inhibitors. However, the wrong choice of an outlier cDNA for dilution series and the standard curve will display, again, different kinetics of the training set and the experimental samples. The choice of the type of standard curve or training set, therefore, depends on the presence of PCR inhibitors in the experimental samples themselves. If they are not inhibited, a training set based on puri®ed PCR product is acceptable, otherwise, a representative experimental sample should be used.
An implementation of KOD was demonstrated on a series of cDNA samples where the expression ratio of two genes was measured, and two estimators of the spread of the results were calculatedÐdistance of ratios containing outliers from the median ratio of their replicates group and CVs of groups of replicate ratios including and excluding the outliers. The outliers identi®ed by KOD gave rise to expression ratios that were signi®cantly different from the median ratio. These aberrant ratios are likely a result of unequal inhibition of the 18S and cyclophilin PCR systems. These results are supported by previous observations of unequal PCR inhibition (9, 10) .
Variable PCR ef®ciency poses an important question whether to use identical PCR ef®ciency for relative quanti®cation (1, 2) or to adopt alternative quanti®cation methods that rely on sample speci®c PCR ef®ciency (8, 9, 11 ). In the current work, no improvement of the results (reduction in spread of replicates) was achieved using Liu and Saint's method. This could be explained by equation 8 that gives the 95% con®dence interval for the signal that corresponds to the expected initial amount of copy number (R 0 ) in a single sample when quanti®ed by Liu and Saint's method (here all symbols as used before) (8): Here we used the EF method for the estimation of PCR ef®ciency and found it accurate and simple to implement, but in principle, KOD can be implemented with any method for estimation of PCR ef®ciency, as long as the same method is used for all samples. We have also tested the method of Tichopad et al. for estimation of PCR ef®ciency, which ®ts the entire ampli®cation curve (15) , and a combination of that method and EF. These approaches yielded poorer results (not shown).
CONCLUSIONS
Real-time PCR is considered the most sensitive method for detection and quanti®cation of nucleic acids since it can detect a single template molecule. Typical samples, however, contain a few tens to many thousands of template molecules. Using KOD one can detect outlier samples with at least 1.3± 1.9-fold error in quanti®cation with a P-value of 0.05. This precision is higher than the minimal 2-fold difference in the number of DNA molecules that real-time PCR usually is claimed to detect (34) .
By excluding aberrant samples from further analysis, false results can be avoided, the spread of results in a group of replicates can be reduced and the potential of real-time PCR to detect smaller differences in DNA amount is improved.
The advantages of KOD were demonstrated here on quanti®cation of gene expression using SYBR Green, but microbial diagnostics, molecular pathology, food analysis, allelic discrimination and virtually any application based on real-time PCR using any of the known chemistries can possibly bene®t from KOD.
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